Anti-Human HBEGF Recombinant Antibody (KHK2866) (CAT#: TAB-340CL)

Recombinant Humanized monoclonal antibody expressed in CHO binding to Human HBEGF. This is a monoclonal antibody targeting anti-heparin-binding EGF-like growth factor (HB-EGF), was being developed for the treatment of dvanced solid tumors and ovarian cancer.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FuncS

Figure 1 Mean serum KHK2866 concentration-time profiles during cycle 1.

Figure 1 Mean serum KHK2866 concentration-time profiles during cycle 1.

Arrows indicate time of weekly dose administration. Error bars indicate standard deviation of the mean. Note: post-dose determination of serum KHK2866 was not performed following the second and third dose except for trough values immediately prior to dose administration indicated at day 14 and 21 time points.

Sarantopoulos, J., Mita, M. M., Birrer, M. J., Cranmer, L. D., Campos, L. T., Zhang, X., ... & Camacho, L. H. (2016). Phase 1 study of monotherapy with khk2866, an anti-heparin-binding epidermal growth factor-like growth factor monoclonal antibody, in patients with advanced cancer. Targeted oncology, 11(3), 317-327.


Specifications

  • Derivation
  • Humanized
  • Type
  • Antibody
  • Species Reactivity
  • Human
  • Applications
  • FuncS
  • Related Disease
  • Solid Tumors

Product Property

  • Purity
  • >95%, by SDS-PAGE, under reducing conditions
  • Storage
  • ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C

Applications

  • Application Notes
  • This antibody has been reported for use in Function Assay.

Target

  • Alternative Names
  • HBEGF; heparin-binding EGF-like growth factor; DTR; DTS; DTSF; HEGFL; proheparin-binding EGF-like growth factor; heparin-binding epidermal growth factor; diphtheria toxin receptor (heparin-binding EGF-like growth factor); diphtheria toxin receptor (hepari

Related Resources

  • Related Diseases

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "HBEGF"

Humanized Antibody

CAT Product Name Application Type
TAB-015CT Anti-Human HB-EGF Recombinant Antibody ELISA, Inhibition, FC Humanized antibody
TAB-015CT-S(P) Anti-Human HB-EGF Recombinant Antibody scFv Fragment ELISA, Inhibition, FC Humanized antibody
TAB-015CT-F(E) Anti-Human HB-EGF Recombinant Antibody Fab Fragment ELISA, Inhibition, FC Humanized antibody

Single-domain Antibody

CAT Product Name Application Type
HPAB-M0387-YC Recombinant Camelid Anti-HBEGF Single Domain Antibody (M/YC-25) ELISA Camelid VHH

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-340CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare